Over the past two decades, more than $22B of direct investment fueled the rapid growth of the oligonucleotide therapeutic market. To illustrate, in 2019, 163 companies were actively working on 542 ...
The oligonucleotide therapeutics market is growing, and the pipeline is diverse. With more than 1200 oligo therapeutics in development and over 20 commercialized oligonucleotide drugs on the market to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results